Frequency of severe neutropenia occurring as an adverse events of gemcitabine plus cisplatin chemotherapy in patients with recurrent biliary tract cancer compared to those with unresectable biliary tract cancer.

Authors

null

Noriko Fujishiro

Center for Research Administration and Support, National Cancer Center Hospital East, Kashiwa, Japan

Noriko Fujishiro , Shuichi Mitsunaga , Akira Shinohara , Misaki K Takeno , Hideki Funazaki , Gen Kimura , Kazuo Watanabe , Kumiko Umemoto , Mitsuhito Sasaki , Hideaki Takahashi , Hiroshi Imaoka , Yusuke Hashimoto , Izumi Ohno , Masafumi Ikeda

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 488)

DOI

10.1200/JCO.2017.35.4_suppl.488

Abstract #

488

Poster Bd #

N6

Abstract Disclosures